losartan has been researched along with Experimental Hepatoma in 5 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saber, S | 1 |
| Mahmoud, AAA | 1 |
| Goda, R | 1 |
| Helal, NS | 1 |
| El-Ahwany, E | 1 |
| Abdelghany, RH | 1 |
| Yoshiji, H | 2 |
| Noguchi, R | 2 |
| Namisaki, T | 2 |
| Moriya, K | 1 |
| Kitade, M | 2 |
| Aihara, Y | 2 |
| Douhara, A | 1 |
| Kawaratani, H | 2 |
| Nishimura, N | 1 |
| Fukui, H | 2 |
| Kaji, K | 1 |
| Ikenaka, Y | 1 |
| Shirai, Y | 1 |
| Yoshii, J | 1 |
| Yanase, K | 1 |
| Tsujimoto, T | 1 |
| Mansour, MA | 1 |
| Al-Ismaeel, H | 1 |
| Al-Rikabi, AC | 1 |
| Al-Shabanah, OA | 1 |
| Cook, JL | 1 |
| Giardina, JF | 1 |
| Zhang, Z | 1 |
| Re, RN | 1 |
5 other studies available for losartan and Experimental Hepatoma
| Article | Year |
|---|---|
Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antineop | 2018 |
Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anticarcinogenic Agents; Antineoplastic Combined C | 2014 |
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
Topics: Administration, Oral; Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blocke | 2011 |
Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver.
Topics: alpha-Fetoproteins; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitor | 2011 |
Intracellular angiotensin II increases the long isoform of PDGF mRNA in rat hepatoma cells.
Topics: Amides; Amino Acid Sequence; Angiotensin II; Animals; Carboxypeptidase H; Carboxypeptidases; Cold Te | 2002 |